FDA Approves Leucovorin Calcium Supplement Application by Ingenus Pharmaceuticals
The FDA has approved the supplemental application ANDA211132 for Leucovorin Calcium submitted by Ingenus Pharmaceuticals.
Company
Pharmaceutical intelligence for Ingenus Pharmaceuticals with 3 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No signals indexed for this entity yet.
No signals indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.